12 · 11 · 2024The Zendal Group Honors Human and Animal Health Innovators at its Fifth Annual Awards GalaLEER MÁS
24 · 10 · 2024Early detection of Alzheimer’s disease and the development of vaccines against ticks in cattle are the objectives of the projects that won the Zendal Prize.LEER MÁS
05 · 07 · 2024Zendal launches first vaccine against Epizootic Haemorrhagic Disease (EHD) in SpainLEER MÁS
28 · 06 · 2024Zendal Group launches the 5th edition of its International Zendal Awards for human and animal health projectsLEER MÁS
20 · 06 · 2024Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVACLEER MÁS
23 · 03 · 2024MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India.LEER MÁS
19 · 12 · 2023IAVI and Zendal announce funding for efficacy trial of promising TB vaccine candidate in AfricaLEER MÁS
14 · 12 · 2023International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.LEER MÁS
20 · 11 · 2023Innovative project against bacterial resistance and a protective vaccine for bees, winners of the Zendal AwardsLEER MÁS
25 · 10 · 2023Zendal launches its human health vaccine manufacturing plant in the Portuguese town of Paredes de CouraLEER MÁS
